Zynerba Competitors and Similar CompaniesClear all
Zynerba's competitors and similar companies include AXIM Biotechnologies.
 Zynerba Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. |  AXIM Biotechnologies AXIM Biotechnologies is a company focused on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. | |
Founding Date | Founding Date 2014 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Devon, US HQ | Locations New York, US HQ San Diego, US |
Employees | Employees 2511% decrease | Employees 6 |
Valuation ($) | Valuation ($) 70.1 m | Valuation ($) 1.5 m |
Financial | ||
Net income | Net income ($35m) (FY, 2022) | Net income ($8.1m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 16.5m | Total funding raised $ 115k |
For sources of this data, please see the company profile
View Company Profiles
AXIM Biotechnologies
HQ
New York, US
Employees
6
AXIM Biotechnologies is a company focused on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products.
View company